
Novartis Settles US Fines Topping $1 Billion
Novartis has finally wrapped up a suite of bribery-related lawsuits in the US, paying well over $1 billion to settle two long running multifaceted cases within a week.
Novartis has finally wrapped up a suite of bribery-related lawsuits in the US, paying well over $1 billion to settle two long running multifaceted cases within a week.
US-based CDMO Catalent has agreed a collaboration with US biotech Moderna for large-scale, commercial fill-finish manufacturing of Moderna’s mRNA-based COVID-19 vaccine candidate (mRNA-1273) at Catalent’s biologics facility in Bloomington, Indiana, USA.
After nearly a year of deliberation, Bayer has clinched a deal to settle three-quarters of its outstanding lawsuits from US plaintiffs who claim that Monsanto’s top-selling herbicide Roundup with the active ingredient glyphosate caused their non-Hodgkins lymphoma (NHL).
Steve Harrington, currently president Global Styrene Monomer and Asia-Pacific at Ineos Styrolution, has been appointed as the Germany-based styrenics manufacturer’s new CEO, succeeding Kevin McQuade, who has been named chairman of the company’s supervisory board.